President Trump is battling for support for his Obamacare replacement but uncertainty abounds regarding how the new plan will play out. Inside Health Policy is the essential health policy news source that can help you sort through the noise of the potentially tumultuous changes ahead.

InsideHealthPolicy.com delivers reporting you won't find elsewhere -- forward-looking news essential for insurers, health care providers, hospitals and other health policy professionals, including pharmaceutical and medical device manufacturers, lawmakers and other government officials, lawyers, consultants and policy advisers.

You can try InsideHealthPolicy.com for the next month with absolutely no obligation. Your trial includes online access to our three health newsletters: Inside CMS, FDA Week and Health Exchange Alert. Plus, if you choose to subscribe, we'll offer you 50% off for the first year of access.

Here are samples of stories you can read with your free trial:

Price, Verma Tell States Medicaid Expansion Isn't Core Mission, Urge Program Redesign
HHS Secretary Tom Price and CMS Administrator Seema Verma wrote to governors Tuesday that Medicaid expansion is "a clear departure from the core, historical mission" of the program, and began overtures to states to revamp the program. They said tax dollars should go to the most vulnerable, urged states to shift to private insurance models and use 1115 waivers to incentivize employment for Medicaid-eligible, poor adults, and said HHS will review all managed care regulations and put off enforcing the 2014 home and community-based services rule.

Trump Focuses CMS' Budget On High Priority Medicare, Medicaid Functions; Hikes Program Integrity
President Donald Trump's "skinny budget" for fiscal 2018 pumps more money into efforts to stem Medicare and Medicaid waste, fraud and abuse, but also signals possible changes to Medicare, Medicaid and the Children's Health Insurance Program by saying agency resources should be focused on the "highest priority activities" necessary to keep the programs running efficiently.

HRSA Again Delays 340B Ceiling Price Rule, Points To Outstanding Questions
The Health Resources and Services Administration again pushed back implementing the 340B ceiling price and civil monetary penalty rule, saying there are still substantial questions about the rule and signaling the administration may be taking a broader overall look at the implementation of 340B drug discounts and how this rule fits in.